8-K: Runway Growth Reports Q4 & FY25 Results, NAV Declines

Runway Growth Finance Corp. announced its fourth quarter and fiscal year 2025 financial results, reporting a decrease in net investment income and net asset value per share.

Summary

• Total investment income for Q4 2025 was $30.0 million, a decrease from $33.8 million in Q4 2024.
• Net investment income for Q4 2025 was $11.6 million, or $0.32 per share, down from $14.6 million, or $0.39 per share, in Q4 2024.
• For fiscal year 2025, total investment income was $137.3 million, compared to $144.6 million in fiscal year 2024.
• Net investment income for fiscal year 2025 was $56.9 million, or $1.55 per share, a decrease from $63.7 million, or $1.64 per share, in fiscal year 2024.
• Net asset value (NAV) per share was $13.42 as of December 31, 2025, a decline from $13.79 as of December 31, 2024.
• The investment portfolio had an aggregate fair value of $927.4 million in 56 companies as of December 31, 2025.
• The dollar-weighted annualized yield on debt investments for Q4 2025 was 14.2%.
• Seven investments were completed in Q4 2025, representing $42.9 million in funded investments.
• Aggregate proceeds of $75.6 million in principal prepayments, $2.2 million from scheduled amortizations, and $0.3 million in equity sale proceeds were received in Q4 2025.
• A first quarter 2026 dividend of $0.33 per share was declared.
• The 8.54% Series 2023A Senior Notes due April 2026 were repaid in full on January 21, 2026.
• On February 3, 2026, $103.25 million in 7.25% unsecured Notes due February 3, 2031, were issued and sold.
• On March 6, 2026, $40.25 million of July 2027 Notes and all $51.75 million of December 2027 Notes were redeemed.
• From January 1, 2026, through March 12, 2026, $54.3 million of additional debt commitments were completed ($5.5 million funded), $2.0 million in equity positions were purchased, $5.5 million in unfunded commitments were funded, and $15.0 million in debt prepayments were received.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mixed report with declining key financial metrics like net investment income and NAV per share, offset by strategic debt refinancing and a positive outlook on future growth and diversification through acquisition.

Positives

• Achieved a strong dollar-weighted annualized yield on debt investments of 14.2% in Q4 2025.
• Maintained a low credit loss ratio of an average 10 basis points per year on a gross basis and an average 7 basis points per year on a net (debt and equity) basis, based on cumulative commitments since inception.
• Successfully managed capital by issuing $103.25 million in 7.25% Notes due 2031 and redeeming higher-interest April 2026 Notes, as well as partially redeeming July 2027 and fully redeeming December 2027 Notes.
• Increased available liquidity to $395.2 million as of December 31, 2025, including $18.2 million in cash and $377.0 million in available borrowing capacity.
• Improved the core leverage ratio to approximately 90% as of December 31, 2025, from 108% for Q4 2024.
• Continued investment activity with $42.9 million funded in Q4 2025 and $54.3 million in additional debt commitments from January 1, 2026, through March 12, 2026.
• The anticipated closing of the proposed acquisition of SWK holdings is expected to expand exposure and capabilities in healthcare and life sciences, contributing to portfolio diversification.

Negatives

• Total investment income decreased to $30.0 million in Q4 2025 from $33.8 million in Q4 2024.
• Net investment income decreased to $11.6 million ($0.32 per share) in Q4 2025 from $14.6 million ($0.39 per share) in Q4 2024.
• Net asset value per share declined to $13.42 as of December 31, 2025, from $13.79 as of December 31, 2024.
• Total net assets decreased by 5.8% to $485.0 million as of December 31, 2025, from $514.9 million as of December 31, 2024.
• Net change in unrealized loss on investments was $3.9 million in Q4 2025, compared to a net change in unrealized gain of $16.5 million in Q4 2024.
• Net increase in net assets resulting from operations significantly decreased to $7.4 million ($0.20 per share) in Q4 2025 from $28.2 million ($0.75 per share) in Q4 2024.
• Total investment portfolio fair value decreased to $927.4 million as of December 31, 2025, from $1,076.8 million as of December 31, 2024.

Risks

• Ongoing macroeconomic volatility could impact investment performance and portfolio company health.
• Actual results may differ materially from forward-looking statements due to various factors, including those described in SEC filings.
• Investment strategies involve special risks that should be carefully evaluated, as detailed in the company's Form 10-K.

Future Outlook

Management is encouraged by the pipeline for the year ahead and plans to deploy capital thoughtfully, leveraging enhanced origination channels. The anticipated closing of the proposed acquisition of SWK holdings is expected to expand exposure and capabilities in healthcare and life sciences, contributing to portfolio diversification.

Management Comments

• "In 2025, Runway Growth leveraged the resources and scale of the BC Partners Credit platform to drive origination volume and optimize our portfolio."
• "Despite ongoing macroeconomic volatility, our disciplined focus on first-lien investments in economically resilient businesses, has positioned us to perform."
• "We are excited about the anticipated closing of our proposed acquisition of SWK holdings, which will expand our exposure and capabilities in healthcare and life sciences as we continue to diversify."
• "Looking at the year ahead, we are encouraged by our pipeline and will continue to deploy capital thoughtfully as we utilize our enhanced origination channels."

Industry Context

StockSavvy.ai notes that Runway Growth's focus on first-lien investments in economically resilient businesses aligns with a broader industry trend towards capital preservation and risk mitigation amidst macroeconomic uncertainties. The proposed acquisition of SWK holdings indicates a strategic move to diversify into specialized sectors like healthcare and life sciences, a common strategy among BDCs seeking stable, high-growth opportunities.

Comparison to Industry Standards

• The 14.2% dollar-weighted annualized yield on debt investments for Q4 2025 is competitive within the BDC sector, particularly for venture debt providers, often exceeding yields from more traditional corporate debt funds.
• The low credit loss ratio (average 10 basis points gross, 7 basis points net) since inception demonstrates strong underwriting and portfolio management, outperforming many peers in the venture debt space who often face higher default rates due to the inherent risk of growth-stage companies.
• The decline in NAV per share from $13.79 to $13.42, and the decrease in net investment income, suggest a challenging operating environment, potentially reflecting broader market pressures or specific portfolio company performance, which warrants comparison with other BDCs reporting similar trends.

Stakeholder Impact

• Shareholders: Impacted by decreased net investment income per share and NAV per share, but will receive a consistent $0.33 per share dividend for Q1 2026.
• Creditors: Positively impacted by the repayment of higher-interest notes and the issuance of new, lower-interest notes, improving the company's debt structure.
• Portfolio Companies: Benefit from continued investment activity and funding of unfunded commitments.
• Employees: No direct impact mentioned, but potential for growth with the SWK acquisition.

Next Steps

• Anticipated closing of the proposed acquisition of SWK holdings.
• Continue to deploy capital thoughtfully, utilizing enhanced origination channels.
• Conference call to discuss Q4 and FY 2025 financial results on March 12, 2026.
• Payment of Q1 2026 dividend of $0.33 per share on March 24, 2026.

Key Dates

Recommendation

While Runway Growth Finance Corp. reported a decline in net investment income and net asset value per share for Q4 and FY 2025, indicating some operational headwinds, the company demonstrated strong capital management by refinancing debt at lower rates and maintaining a healthy yield on its debt investments. The strategic acquisition of SWK holdings and a positive outlook on future origination provide potential for long-term growth and diversification. Given the mixed results, a 'hold' recommendation is appropriate, allowing investors to monitor the integration of SWK holdings and the execution of capital deployment strategies in the coming quarters.

Keywords

Runway Growth Finance, RWAY, BDC, Business Development Company, Venture Debt, Growth Stage Companies, Financial Results, Investment Income, Net Asset Value, SEC Filing, Q4 2025, FY 2025, Debt Investments, Capital Solutions, BC Partners Credit, SWK Holdings Acquisition, Corporate Debt